News
Micro Inverter Market Micro Inverter Market to grow from USD 2.8 Bn in 2022 to USD 8.5 Bn by 2031, at a CAGR of 20.5% during 2024–2031.
The Japan is exceptionally positioned for explosive growth in the smart solar inverter market. Driven by mandatory grid-code upgrades, a massive post ...
California-based solar battery manufacturer Enphase Energy (NASDAQ:ENPH) is set to announce its second quarter earnings on Tuesday, July 22nd, after the closing bell. Street expects the company to ...
ActionPower has released a modular programmable ac and dc power supply and load, aimed at testing photovoltaic ...
Enphase Energy (NASDAQ:ENPH) +4.6% in Wednesday's trading as one of the day's biggest gainers on the S&P 500, and Solaredge Technologies (SEDG) +3.3%, despite downgrades by Goldman Sachs, which warned ...
The U.S. Army Corps of Engineers announced that the remaining Phase 3 construction options have been awarded for the new lock project at the Soo Locks.
Enphase’s IQ8 Commercial Microinverters to Equip Nearly 3 MW of New Solar Installations in Florida, Rhode Island, and California ...
NAPOLI 3, a phase 3 study of NALIRIFOX in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Final overall survival (OS) analysis and characteristics of the long-term survivors.
NAPOLI 3, a phase 3 study of NALIRIFOX in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Final overall survival (OS) analysis and characteristics of the long-term survivors.
Diverse combinations of ionic liquids (ILs), anions, and cations can effectively regulate the properties of the three-phase interface catalytic microenvironment, which determine the dissolution and ...
In the Phase 3 AFFIRM-AL clinical trial, the primary endpoint of time to all-cause mortality was not met for patients treated with birtamimab.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results